Inactive Instrument

Gelesis Inc Stock

Equities

End-of-day quote Nasdaq Other stock markets
- ^USD	-

Gelesis Expands Ongoing Weight Loss Study to Serve as U.S. Pivotal Trial, Significantly Accelerating Development Timeline	15-07-27	GL
Gelesis Presents Additional Data at European Congress on Obesity	15-05-22	GL

Managers	Title	Age	Since
David Pass COO	Chief Operating Officer	56	16-08-31
Angelo Tremblay PRN	Corporate Officer/Principal	-	-
Cosimo Saponaro PRN	Corporate Officer/Principal	-	-

Members of the board	Title	Age	Since
Clayton Christopher BRD	Director/Board Member	51	-
Kathryn Cavanaugh BRD	Director/Board Member	50	21-12-31
Alison Bauerlein BRD	Director/Board Member	42	22-01-04

Sector

	1st Jan change	Capi.
SAMSUNG BIOLOGICS CO.,LTD.	+1.45%	40.51B
BIOGEN INC.	-15.94%	31.67B
UCB	+52.66%	24.62B
BIOMARIN PHARMACEUTICAL INC.	-14.50%	15.65B
INCYTE CORPORATION	-14.38%	12.07B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-9.12%	11.97B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-42.56%	11.61B
SWEDISH ORPHAN BIOVITRUM AB	+4.87%	8.81B
INNOVENT BIOLOGICS, INC.	-4.33%	8.5B